The pharmaceutical industry relies heavily on a precise and consistent supply of intermediates to produce life-saving medications. One such critical compound is 4,6-Dihydroxy-2-methylpyrimidine (CAS: 40497-30-1), widely recognized for its role as a key intermediate in the synthesis of Moxonidine, a significant antihypertensive drug. For pharmaceutical companies looking to buy this essential component, understanding its characteristics and the advantages of sourcing from specialized manufacturers is vital.
4,6-Dihydroxy-2-methylpyrimidine: A Cornerstone for Moxonidine Synthesis
Moxonidine's therapeutic efficacy is directly linked to the quality of its synthetic precursors. 4,6-Dihydroxy-2-methylpyrimidine, with its specific pyrimidine structure and reactive hydroxyl groups, is instrumental in the multi-step process of creating Moxonidine. The compound's high purity, typically assayed at ≥98.0%, ensures that the synthesis proceeds efficiently, minimizing impurities that could affect the final drug product's safety and efficacy. The ability to readily transform this intermediate, for instance, into 4,6-dichloro-2-methyl-pyrimidine, highlights its strategic importance in pharmaceutical manufacturing workflows.
Why Partner with a Specialized Manufacturer?
When sourcing a critical intermediate like 4,6-Dihydroxy-2-methylpyrimidine, partnering with an experienced manufacturer offers numerous benefits. These include:
Sourcing Moxonidine Intermediates in the Market
As the demand for effective antihypertensive treatments continues to grow, so does the need for reliable sources of Moxonidine intermediates. Companies that are looking to purchase 4,6-Dihydroxy-2-methylpyrimidine should prioritize suppliers who demonstrate a deep understanding of the pharmaceutical industry's requirements. Obtaining clear price quotes and understanding delivery timelines from a trusted 4,6-Dihydroxy-2-methylpyrimidine supplier are crucial steps in securing your supply chain.
In essence, 4,6-Dihydroxy-2-methylpyrimidine is an indispensable component for the production of Moxonidine. By collaborating with capable manufacturers and focusing on quality assurance, pharmaceutical companies can ensure a stable supply of this critical intermediate, thereby supporting their mission to deliver high-quality healthcare solutions.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.